Josep Nomdedeu

11PUBLICATIONS
64CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Regenerative medicine (incl. stem cells)NeonatologyMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Aug 28, 2025
Telomere attrition becomes an instrument for clonal selection in aging hematopoiesis and leukemogenesis.

Matthew A McLoughlin, Sruthi Cheloor Kovilakam, William G Dunn

|Jan 11, 2025
Diverse real-life outcomes after intensive risk-adapted therapy for 1034 AML patients from the CETLAM Group.

Guadalupe Oñate, Ana Garrido, Montserrat Arnan

|May 05, 2023
Survival improvement of patients with FLT3 mutated acute myeloid leukemia: results from a prospective 9 years cohort.

Guadalupe Oñate, Marta Pratcorona, Ana Garrido

|Sep 01, 2021
Engraftment characterization of risk-stratified AML in NSGS mice.

Rafael Díaz de la Guardia, Talía Velasco-Hernandez, Francisco Gutiérrez-Agüera

|Dec 28, 2020
Many signs, one mutation: Early onset of de novo GATA2 deficiency syndrome. A case report.

Maria Laura Blanco, Montserrat Torrent, Elena Bussaglia

|Feb 27, 2020
The complex genetic landscape of familial MDS and AML reveals pathogenic germline variants.

Ana Rio-Machin, Tom Vulliamy, Nele Hug

Pageof 2